Amneal Pharmaceuticals recalled 14,923 bottles of Chlorpromazine Hydrochloride Tablets on August 18, 2025. A specific lot of polyester coil used in product packaging tested positive for a micro-organism. No contamination was found in the tablets themselves.
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
Consumers and healthcare providers should stop using this product immediately. Contact Amneal Pharmaceuticals, LLC or your healthcare provider for guidance. Notification method: Letter
The recalled product is Chlorpromazine Hydrochloride Tablets, 100 mg in 100-count bottles. The affected lot numbers include AM240334, AM240335, and AM241031. The tablets were distributed nationwide in the USA.
The recall stems from the presence of a foreign substance in the packaging. A specific lot of auxiliary polyester coil tested positive for a micro-organism, posing potential health risks.
No incidents or injuries related to the contamination have been reported. The tablets themselves remain uncontaminated.
Stop using the recalled product immediately. Contact Amneal Pharmaceuticals or your healthcare provider for further guidance.
For more information, call Amneal Pharmaceuticals at 1-800-XXX-XXXX or visit their website at www.amneal.com.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.